Rolapitant Drug Interactions
Currently displaying a list of 235 drugs known to interact with rolapitant.
- 26 major drug interactions
- 201 moderate drug interactions
- 8 minor drug interactions
Medications known to interact with rolapitant
Note: Showing generic names only.
A
- abametapir topical
- adagrasib
- afatinib
- aliskiren
- alpelisib
- aminoglutethimide
- amitriptyline
- amobarbital
- amphetamine
- apalutamide
- apixaban
- aripiprazole
- armodafinil
- artesunate
- atomoxetine
B
- belzutifan
- benzgalantamine
- berotralstat
- betrixaban
- bexarotene
- binimetinib
- bosentan
- bosutinib
- brentuximab
- brexpiprazole
- butabarbital
- butalbital
C
- carbamazepine
- carvedilol
- cenobamate
- ceritinib
- chlorpheniramine
- chlorpromazine
- clomipramine
- clozapine
- cobimetinib
- codeine
- colchicine
- cyclosporine
D
- dabigatran
- daclatasvir
- daridorexant
- darifenacin
- daunorubicin
- daunorubicin liposomal
- deferasirox
- desipramine
- dexamethasone
- dexfenfluramine
- dextroamphetamine
- dextromethorphan
- digoxin
- diphenhydramine
- docetaxel
- donepezil
- doxepin
- doxepin topical
- doxorubicin
- doxorubicin liposomal
- duloxetine
E
- echinacea
- edoxaban
- efavirenz
- elafibranor
- elagolix
- eliglustat
- encorafenib
- enfortumab vedotin
- ensartinib
- enzalutamide
- epirubicin
- erlotinib
- erythromycin
- eslicarbazepine
- etoposide
- etravirine
- everolimus
F
- felbamate
- fenfluramine
- fexofenadine
- fidaxomicin
- flecainide
- flibanserin
- fluoxetine
- fluphenazine
- fluvoxamine
- fosphenytoin
G
H
I
L
- lapatinib
- larotrectinib
- lemborexant
- lenacapavir
- linagliptin
- lisdexamfetamine
- lonapegsomatropin
- loperamide
- lorlatinib
- lusutrombopag
M
- maprotiline
- maraviroc
- mavacamten
- mavorixafor
- meclizine
- mephobarbital
- mesoridazine
- methadone
- methamphetamine
- methotrexate
- methotrimeprazine
- metoclopramide
- metoprolol
- metreleptin
- mexiletine
- midodrine
- mirtazapine
- mitapivat
- mitotane
- mitoxantrone
- mobocertinib
- modafinil
- morphine
N
O
P
- paclitaxel
- paclitaxel protein-bound
- pacritinib
- paroxetine
- pazopanib
- pentobarbital
- perphenazine
- pexidartinib
- phenobarbital
- phenylbutazone
- phenytoin
- pimozide
- pirfenidone
- pirtobrutinib
- pitolisant
- posaconazole
- pralsetinib
- primidone
- promethazine
- propafenone
- propoxyphene
- propranolol
- protriptyline
- prucalopride
Q
R
- ranolazine
- relugolix
- repotrectinib
- rifabutin
- rifampin
- rifapentine
- rifaximin
- rimegepant
- ripretinib
- risperidone
- ritonavir
- rivaroxaban
- romidepsin
- rosuvastatin
- rufinamide
S
- saxagliptin
- secobarbital
- seladelpar
- silodosin
- sirolimus
- sitagliptin
- sofpironium topical
- somapacitan-beco
- somatrem
- somatrogon
- somatropin
- sotorasib
- st. john's wort
- sulfasalazine
- sulfinpyrazone
- suzetrigine
T
- talazoparib
- tamoxifen
- tamsulosin
- tazemetostat
- tecovirimat
- telotristat
- teriflunomide
- tetrabenazine
- thioridazine
- ticagrelor
- timolol
- timolol ophthalmic
- tipranavir
- tolterodine
- tolvaptan
- topotecan
- tovorafenib
- tramadol
- trazodone
- trimipramine
- trofinetide
- troglitazone
U
V
- vemurafenib
- venetoclax
- vibegron
- vinblastine
- vincristine
- vincristine liposome
- vinorelbine
- vorasidenib
- vortioxetine
Rolapitant disease interactions
There are 3 disease interactions with rolapitant which include:
Report options
QR code containing a link to this page
More about rolapitant
- rolapitant consumer information
- Check interactions
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: NK1 receptor antagonists
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
